These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21217649)

  • 1. Clinical drive prompts pharma and academia to partner up.
    Scudellari M
    Nat Med; 2011 Jan; 17(1):3. PubMed ID: 21217649
    [No Abstract]   [Full Text] [Related]  

  • 2. The quiet rise of the clinical contractor.
    Wadman M
    Nature; 2006 May; 441(7089):22-3. PubMed ID: 16672945
    [No Abstract]   [Full Text] [Related]  

  • 3. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reinventing an industry.
    Mandavilli A
    Nature; 2007 Jan; 445(7124):138-9. PubMed ID: 17215817
    [No Abstract]   [Full Text] [Related]  

  • 5. Entering the contract research industry in India.
    Joseph J
    Contemp Clin Trials; 2008 May; 29(3):311-3. PubMed ID: 18053773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commercializing clinical trials--risks and benefits of the CRO boom.
    Shuchman M
    N Engl J Med; 2007 Oct; 357(14):1365-8. PubMed ID: 17914036
    [No Abstract]   [Full Text] [Related]  

  • 7. Indian pharma enters the global arena.
    Singh S
    Cell; 2007 Mar; 128(5):811-4. PubMed ID: 17350563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Billion-dollar market blossoms as botanicals take root.
    Glaser V
    Nat Biotechnol; 1999 Jan; 17(1):17-8. PubMed ID: 9920256
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative analysis of quality management standards for contract research organisations in clinical trials.
    Murray E; McAdam R
    Int J Health Care Qual Assur; 2007; 20(1):16-33. PubMed ID: 18240505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug patents distort research].
    Magnusson PA
    Lakartidningen; 2008 Apr 2-8; 105(14):1032. PubMed ID: 18478758
    [No Abstract]   [Full Text] [Related]  

  • 11. Outsourcing strategy: local versus international contract research organizations.
    Zimmer D
    Bioanalysis; 2014 May; 6(10):1279-81. PubMed ID: 24958110
    [No Abstract]   [Full Text] [Related]  

  • 12. True, false, whatever.
    Schultz S
    US News World Rep; 2001 Sep; 131(10):72-3. PubMed ID: 11573469
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharma patents in Europe: where are we going?
    Becker K
    Future Med Chem; 2009 May; 1(2):227-30. PubMed ID: 21425963
    [No Abstract]   [Full Text] [Related]  

  • 14. Sending pharma better signals.
    Avorn J
    Science; 2005 Jul; 309(5735):669. PubMed ID: 16051753
    [No Abstract]   [Full Text] [Related]  

  • 15. Innovation and compliance are not diametrically opposed.
    Raab GK
    Qual Assur; 1994 Mar; 3(1):2-8. PubMed ID: 7804614
    [No Abstract]   [Full Text] [Related]  

  • 16. Patents discipline is key to securing big pharma investment.
    Jones N
    Drug Discov Today; 2012 Jan; 17(1-2):1-2. PubMed ID: 22138380
    [No Abstract]   [Full Text] [Related]  

  • 17. European researchers up in arms over new clinical trials edict.
    Bosch X
    Nat Med; 2003 Nov; 9(11):1336. PubMed ID: 14595413
    [No Abstract]   [Full Text] [Related]  

  • 18. Opening up the Ivory Tower.
    Wilan KH
    Cell; 2007 Jun; 129(5):847-50. PubMed ID: 17540161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Academic centers get turnaround advice.
    Japsen B
    Mod Healthc; 1995 Sep; 25(37):50, 52. PubMed ID: 10151382
    [No Abstract]   [Full Text] [Related]  

  • 20. Sponsorship, authorship and accountability.
    Relman AS
    N Z Med J; 2001 Dec; 114(1145):558; author reply 559. PubMed ID: 11833958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.